Renal Cancer
Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features.
December 5, 2018
Structure base Virtual screening for the identification of high affinity compounds as potent VEGFR2 inhibitors for the treatment of Renal Cell Carcinoma.
December 5, 2018
Metastatic clear cell renal carcinoma to the auricular region disguised as a vascular thrombus: Case report.
December 5, 2018
Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease.
December 5, 2018
Efficacy, safety, and prognostic indicators of first-line sunitinib in patients with metastatic renal cell carcinoma: A single center experience.
December 4, 2018
miR‑122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3.
December 4, 2018
Cabozantinib versus Everolimus in Advanced Renal Cell Carcinoma (METEOR): Final Results from a Randomised, Open-label, Phase 3 Trial
December 3, 2018
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma
December 3, 2018
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
December 3, 2018
CircPCNXL2 sponges miR-153 to promote the proliferation and invasion of renal cancer cells through upregulating ZEB2.
December 3, 2018
Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival.
December 3, 2018
Mitochondrial PIWI-interacting RNAs are novel biomarkers for clear cell renal cell carcinoma.
December 3, 2018
Mutations in renal cell carcinoma.
November 30, 2018